XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow-to-Debt Ratio
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow-to-Debt Ratio of -10.73x as of December 2022, meaning its operating cash flow of $-2.01 Million could theoretically repay -11% of its total liabilities ($187.00K) in one year. See XTL Biopharmaceuticals Ltd ADR free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
XTL Biopharmaceuticals Ltd ADR Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for XTL Biopharmaceuticals Ltd ADR across 22 annual periods. Also explore XTLB net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for XTL Biopharmaceuticals Ltd ADR (2003–2024)
Year-by-year debt coverage analysis for XTL Biopharmaceuticals Ltd ADR. For market capitalisation and broader financial context, see XTL Biopharmaceuticals Ltd ADR (XTLB) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.52x | $-1.62 Million | $3.12 Million | ▲ +84.9% |
| 2023 | -3.43x | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.35x | $-850.00K | $254.00K | ▲ +14.5% |
| 2019 | -3.91x | $-908.00K | $232.00K | ▼ -21.3% |
| 2018 | -3.23x | $-816.00K | $253.00K | ▼ -750.6% |
| 2017 | -0.38x | $-1.12 Million | $2.97 Million | ▲ +92.8% |
| 2016 | -5.25x | $-1.73 Million | $330.00K | ▼ -23.0% |
| 2015 | -4.27x | $-1.86 Million | $436.00K | ▼ -66.8% |
| 2014 | -2.56x | $-2.47 Million | $965.00K | ▼ -26.0% |
| 2013 | -2.03x | $-2.50 Million | $1.23 Million | ▼ -124.2% |
| 2012 | -0.91x | $-1.51 Million | $1.66 Million | ▲ +68.4% |
| 2011 | -2.86x | $-1.80 Million | $629.00K | ▼ -275.1% |
| 2010 | -0.76x | $-735.00K | $963.00K | ▲ +78.3% |
| 2009 | -3.51x | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $2.00 Million | ▼ -36.9% |
| 2007 | -3.86x | $-21.46 Million | $5.56 Million | ▼ -26.9% |
| 2006 | -3.04x | $-12.59 Million | $4.14 Million | ▼ -13.3% |
| 2005 | -2.68x | $-10.47 Million | $3.90 Million | ▼ -11.5% |
| 2004 | -2.41x | $-14.49 Million | $6.02 Million | ▲ +23.3% |
| 2003 | -3.14x | $-13.33 Million | $4.25 Million | — |